Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
The goal of this study was to explore the efficacy and safety of neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy in patients with locally advanced esophageal squamous cell carcinoma
Esophageal Squamous Cell Carcinoma
PROCEDURE: Neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy
pCR, Pathologic Complete Response, immediately after the intervention/procedure/surgery
R0 resection rate, R0 resection rate, immediately after the intervention/procedure/surgery
1#3-year disease free survival, 1#3-year disease free survival, immediately after the intervention/procedure/surgery
The goal of this study was to explore the efficacy and safety of neoadjuvant chemoimmunotherapy followed by surgery and postoperative radioimmunotherapy in patients with locally advanced esophageal squamous cell carcinoma